Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocellular carcinoma. Pathogenesis and multicentricity].

H E Blum1, U T Hopt

  • 1Abteilung Innere Medizin II, Medizinische Universitätsklinik, Freiburg.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|August 21, 2003
PubMed
Summary

Hepatocellular carcinoma (HCC), a complex liver cancer, has a poor prognosis due to genetic mutations and instability. Current treatments show limited success, highlighting the need for better therapeutic strategies for this common malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Cell death and differentiation·2015
Same author

[Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Sofosbuvir: alternative in hepatitis C infection?].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Reforming the EU environment for clinical trials: what are the challenges?

QJM : monthly journal of the Association of Physicians·2013
Same author

[Pathology: pacemaker of advances in medicine].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.

Transplant infectious disease : an official journal of the Transplantation Society·2012

Area of Science:

  • Hepatology
  • Oncology
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent malignancy with a dismal prognosis.
  • Its complex pathogenesis involves genetic alterations, tumor suppressor genes, oncogenes, and genetic instability.
  • Chronic liver disease contributes to HCC development through enhanced cell regeneration and mitotic activity.

Purpose of the Study:

  • To provide a comprehensive overview of the molecular pathogenesis of Hepatocellular Carcinoma (HCC).
  • To discuss the challenges in prognosis and current therapeutic strategies for HCC.
  • To highlight the resistance of HCC to conventional treatments.

Main Methods:

  • Review of existing literature on HCC molecular pathogenesis.
  • Analysis of genetic alterations, including mutations and instability.

Related Experiment Videos

  • Evaluation of current treatment modalities and their efficacy.

    • Main Results:

    • HCC pathogenesis is characterized by complex genetic mutations and instability.
    • Prognosis for symptomatic HCC patients is extremely poor, with low survival rates.
    • HCC demonstrates significant resistance to radio- and chemotherapy.

    Conclusions:

    • Understanding the molecular basis of HCC is crucial for improving patient outcomes.
    • Current therapeutic strategies have limited efficacy, necessitating further research.
    • Novel treatment approaches are required to combat HCC's resistance to therapy.